FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
-27.08%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$189M
AUM Growth
+$189M
(-30%)
Cap. Flow
-$3.7M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
2
Increased
3
Reduced
3
Closed
2
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$7.51M |
| 2 |
Twist Bioscience
TWST
|
$1.68M |
| 3 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$1.15M |
| 4 |
Natera
NTRA
|
$964K |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$773K |
Top Sells
| 1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$7.94M |
| 2 |
Denali Therapeutics
DNLI
|
$5.44M |
| 3 |
Sangamo Therapeutics
SGMO
|
$1.36M |
| 4 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$564K |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$464K |
Sector Composition
| 1 | Healthcare | 30.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIMT
1
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $71M | 37.63% | 2,968,649 -332,148 | -10% | -$7.94M |
|
|
AERI
2
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $60.4M | 32% | 1,672,714 +207,965 | +14% | +$7.51M |
|
|
ALDR
3
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $16.3M | 8.62% | 1,586,220 | – | – |
|
4
Insmed
INSM
$28.8B
| $12.7M | 6.73% | 967,636 | – | – |
|
|
EPZM
5
DELISTED
Epizyme, Inc
EPZM
| $9.6M | 5.09% | 1,557,864 +125,500 | +9% | +$773K |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $9.13M | 4.84% | 209,602 -10,666 | -5% | -$464K |
|
|
ADAP
7
Adaptimmune Therapeutics
ADAP
$15.6M
| $4.03M | 2.13% | 700,000 +200,000 | +40% | +$1.15M |
|
|
BDSI
8
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.95M | 1.56% | 796,733 -152,500 | -16% | -$564K |
|
|
9
Twist Bioscience
TWST
$1.63B
| $1.68M | 0.89% | +72,849 | New | +$1.68M |
|
|
10
Natera
NTRA
$23.1B
| $964K | 0.51% | +69,045 | New | +$964K |
|
|
11
Denali Therapeutics
DNLI
$2.23B
| – | – | -250,000 | Closed | -$5.44M |
|
|
12
Sangamo Therapeutics
SGMO
$157M
| – | – | -80,500 | Closed | -$1.36M |
|